Bifidobacterium breve M-16V

Introduction

Microbiology
Profile
  • Gram positive
  • Rod shape
  • Anaerobic bacteria
    		•
    no img yet
    Bifidobacterium animalis M-16V
    Functions
  • Relieve lactose intolerance
  • Modulation of intestinal microbiota
    		•
    Origin First found in infant gut.
    Genome

    Functional Studies

    Clinical Trials or Animal Experiments
    ID Category Subject Title Year
    1 clinical trial necrotising enterocolitis (NEC) Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial 2014
    2 clinical trial intrauterine growth restriction (IUGR) Effect of Bifidobacterium breve M-16V supplementation on faecal bifidobacteria in growth restricted very preterm infants - analysis from a randomised trial 2016
    3 clinical trial allergic rhinitis (AR), allergic asthma Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma 2017
    4 clinical trial atopic dermatitis (AD) No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis 2012
    5 clinical trial modulate gut microbiota Effect of Synbiotic on the Gut Microbiota of Cesarean Delivered Infants: A Randomized, Double-blind, Multicenter Study 2017
    6 clinical trial modulate gut microbiota A synbiotic-containing amino-acid-based formula improves gut microbiota in non-IgE-mediated allergic infants 2018
    7 clinical trial irritable bowel syndrome (IBS), functional dyspepsia (FD) A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial 2017
    8 clinical trial atopic dermatitis (AD) Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis 2018
    9 clinical trial atopic dermatitis (AD) Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis 2011
    10 clinical trial cow's milk allergy (CMA) Synbiotics-supplemented amino acid-based formula supports adequate growth in cow's milk allergic infants 2015
    11 clinical trial atopic dermatitis (AD) Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial 2010
    12 clinical trial allergy Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota 2014
    13 clinical trial allergic asthma Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics 2011
    14 clinical trial neuropsychological development Difficulties in developmental follow-up of preterm neonates in a randomised-controlled trial of Bifidobacterium breve M16-V - Experience from Western Australia 2020
    15 clinical trial atopic dermatitis (AD) Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis 2003
    16 animal experiment immunity The Combination of Bifidobacterium breve and Three Prebiotic Oligosaccharides Modifies Gut Immune and Endocrine Functions in Neonatal Mice 2019
    17 animal experiment allergy Post-sensitization administration of non-digestible oligosaccharides and Bifidobacterium breve M-16V reduces allergic symptoms in mice 2016
    18 animal experiment allergy Dietary, nondigestible oligosaccharides and Bifidobacterium breve M-16V suppress allergic inflammation in intestine via targeting dendritic cell maturation 2017
    19 animal experiment cow's milk allergy (CMA) Dietary Intervention with β-Lactoglobulin-Derived Peptides and a Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates the Prevention of Whey-Induced Allergy in Mice by Supporting a Tolerance-Prone Immune Environment 2017
    20 animal experiment allergy A Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates Partial Non-Responsiveness to Whey Protein in Mice Orally Exposed to β-Lactoglobulin-Derived Peptides 2017
    21 animal experiment allergic asthma The development of allergic inflammation in a murine house dust mite asthma model is suppressed by synbiotic mixtures of non-digestible oligosaccharides and Bifidobacterium breve M-16V 2016
    22 animal experiment immunity Multi-omics reveals that Bifidobacterium breve M-16V may alleviate the immune dysregulation caused by nanopolystyrene 2022
    23 animal experiment allergic lung inflammation Maternal supplementation with Bifidobacterium breve M-16V prevents their offspring from allergic airway inflammation accelerated by the prenatal exposure to an air pollutant aerosol 2020
    24 animal experiment allergy Suppressive effects of bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model 2009
    25 animal experiment food allergy (FA) Bifidobacterium breve M-16V alters the gut microbiota to alleviate OVA-induced food allergy through IL-33/ST2 signal pathway 2020
    26 animal experiment cow's milk allergy (CMA) Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey 2009
    27 animal experiment allergy Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study 2010
    28 clinical trial, animal experiment allergy Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans 2012
    29 animal experiment immunity Differences between live and heat-killed bifidobacteria in the regulation of immune function and the intestinal environment 2017

    Links (further search of Bifidobacterium breve M-16V)